Thomas Klimkait

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Viruses

PLoS pathogens

Nature communications

PLoS medicine

University of Basel

University of Cologne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Basel

Switzerland

Research Group Leader :: Department Biomedicine

Education History

University of Cologne

Germany

PHD :: Institute of Virology

Publications

Yuepeng Zhang, Fabian Otte, Marcel Stoeckle, Alexander Thielen, Martin Däumer, Rolf Kaiser, Katharina Kusejko, Karin J Metzner, Thomas Klimkait, null null
HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond. PLoS pathogens 20 (9) (2024)
Ulrike Seeburg, Lorena Urda, Fabian Otte, Martin J Lett, Silvia Caimi, Christian Mittelholzer, Thomas Klimkait
Virus Inactivation by Formaldehyde and Common Lysis Buffers. Viruses 15 (8) (2023)
Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, Christopher M R Lang, Mohamed Chami, Christian Mittelholzer, Thomas Klimkait
Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform. eLife 12 (2023)
Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, Christopher M R Lang, Mohamed Chami, Christian Mittelholzer, Thomas Klimkait
Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform. bioRxiv : the preprint server for biology (2023)
Lorena Urda, Matthias Heinrich Kreuter, Juergen Drewe, Georg Boonen, Veronika Butterweck, Thomas Klimkait
The Petasites hybridus CO 2 Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro. Viruses 14 (1) (2022)
Jennifer Anne Brown, Bienvenu L Nsakala, Kuena Mokhele, Itumeleng Rakuoane, Josephine A Muhairwe, Tracy R Glass, Alain Amstutz, Nadine Tschumi, Jennifer M Belus, Thomas Klimkait, Niklaus Daniel Labhardt
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. HIV medicine (2022)
Christian Mittelholzer, Thomas Klimkait
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses. Viruses 14 (12) (2022)
Babalwa Tembeni, Amanda Sciorillo, Luke Invernizzi, Thomas Klimkait, Lorena Urda, Phanankosi Moyo, Dashnie Naidoo-Maharaj, Nathan Levitties, Kwasi Gyampoh, Guorui Zu, Zhe Yuan, Karam Mounzer, Siphathimandla Nkabinde, Magugu Nkabinde, Nceba Gqaleni, Ian Tietjen, Luis J Montaner, Vinesh J Maharaj
HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala ( Thymelaeaceae ). Viruses 14 (7) (2022)
Christian Mittelholzer, Thomas Klimkait
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses. Viruses 14 (12) (2022)
Christian Mittelholzer, Thomas Klimkait
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses. Viruses 14 (12) (2022)
David Seifert, Beda Joos, Dominique L Braun, Corinna S Oberle, Corinne D Schenkel, Herbert Kuster, Christina Grube, Jürg Böni, Sabine Yerly, Vincent Aubert, Thomas Klimkait, Huldrych F Gunthard, Niko Beerenwinkel, Karin J Metzner, null On Behalf Of The Swiss Hiv Cohort Study
Detecting Selection in the HIV-1 Genome during Sexual Transmission Events. Viruses 14 (2) (2022)
Christian Mittelholzer, Thomas Klimkait
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses. Viruses 14 (12) (2022)
Christian Mittelholzer, Thomas Klimkait
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses. Viruses 14 (12) (2022)
Alain Amstutz, Thabo Ishmael Lejone, Lefu Khesa, Mathebe Kopo, Mpho Kao, Josephine A Muhairwe, Moniek Bresser, Fabian Räber, Thomas Klimkait, Manuel Battegay, Tracy Renée Glass, Niklaus Daniel Labhardt
Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial. PLoS medicine 18 (10) (2021)
Jennifer Anne Brown, Herbert A Mbunkah, Thabo Ishmael Lejone, Isaac Ringera, Molisana Cheleboi, Thomas Klimkait, Karin J Metzner, Huldrych F Gunthard, Niklaus Daniel Labhardt, Roger D Kouyos, Nadine Tschumi
Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study. Open forum infectious diseases 8 (5) (2021)
Chenjie Wan, Nadine Tschumi, Venelin Mitov, François Blanquart, Susana Posada Céspedes, Teja Turk, Kathrin Neumann, Niko Beerenwinkel, Jasmina Bogojeska, Jacques Fellay, Volker Roth, Katharina Kusejko, Matthieu Perreau, Thomas Klimkait, Sabine Yerly, Manuel Battegay, Laura Walti, Alexandra Calmy, Pietro Vernazza, Enos Bernasconi, Matthias Cavassini, Karin J Metzner, Huldrych F Gunthard, Roger D Kouyos, null null
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART. Nature communications 11 (1) (2020)
Alain Amstutz, Bienvenu Lengo Nsakala, Fiona Vanobberghen, Josephine A Muhairwe, Tracy Renée Glass, Tilo Namane, Tlali Mpholo, Manuel Battegay, Thomas Klimkait, Niklaus Daniel Labhardt
Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho. PLoS medicine 17 (9) (2020)
Nadine Tschumi, Chantal von Siebenthal, Valentina Vongrad, Teja Turk, Kathrin Neumann, Niko Beerenwinkel, Jasmina Bogojeska, Jacques Fellay, Volker Roth, Yik Lim Kok, Christian W Thorball, Alessandro Borghesi, Sonali Parbhoo, Mario Wieser, Katharina Kusejko, Matthieu Perreau, Thomas Klimkait, Sabine Yerly, Manuel Battegay, Andri Rauch, Matthias Hoffmann, Enos Bernasconi, Matthias Cavassini, Roger D Kouyos, Huldrych F Gunthard, Karin J Metzner, null null
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART. Nature communications 10 (1) (2019)
Claus Kadelka, Thomas Liechti, Hanna Ebner, Merle Schanz, Peter Rusert, Nikolas Friedrich, Emanuel Stiegeler, Dominique L Braun, Michael Huber, Alexandra U Scherrer, Jacqueline Weber, Therese Uhr, Herbert Kuster, Benjamin Misselwitz, Matthias Cavassini, Enos Bernasconi, Matthias Hoffmann, Alexandra Calmy, Manuel Battegay, Andri Rauch, Sabine Yerly, Vincent Aubert, Thomas Klimkait, Katharina Kusejko, Roger D Kouyos, Huldrych F Gunthard, Alexandra Trkola, null null
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity. The Journal of experimental medicine 215 (6) (2018)
Denise Kühnert, Roger D Kouyos, George Shirreff, Jūlija Pečerska, Alexandra U Scherrer, Katharina Kusejko, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Huldrych F Günthard, Tanja Stadler, Sebastian Bonhoeffer, null null
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics. PLoS pathogens 14 (2) (2018)

Thomas Klimkait.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Klimkait